Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression-Reference-Cited by-同舟云学术

Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression

Published:2022-12 Issue:6 Volume:5 Page:617-627
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Baboudjian Michael,Breda Alberto,Rajwa Pawel,Gallioli Andrea,Gondran-Tellier Bastien,Sanguedolce Francesco,Verri Paolo,Diana Pietro,Territo Angelo,Bastide Cyrille,Spratt Daniel E.,Loeb Stacy,Tosoian Jeffrey J.,Leapman Michael S.,Palou Joan,Ploussard Guillaume

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference49 articles.

1. Screening and prostate-cancer mortality in a randomized European study;Schröder;N Engl J Med,2009

2. Observational studies and the natural history of screen-detected prostate cancer;Albertsen;Curr Opin Urol,2015

3. Quality of life and satisfaction with outcome among prostate-cancer survivors;Sanda;N Engl J Med,2008

4. EAU. EAU guidelines. Presented at the EAU Annual Congress Amsterdam, 2022. ISBN 978-94-92671-16-5.

5. Clinically localized prostate cancer: AUA/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up;Eastham;J Urol,2022

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI at diagnostic versus confirmatory biopsy during MRI-based active surveillance of prostate cancer;Urologic Oncology: Seminars and Original Investigations;2024-10

2. Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder’s Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging–visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003;European Urology;2024-09

3. Reply to Andrew J. Vickers’ Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging–visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003;European Urology;2024-09

4. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?;European Urology;2024-09

5. Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective ‘ablate‐and‐resect’ study;BJU International;2024-05-14